Overview

Major advances in technology have a ripple effect through diverse aspects of industry and society. CAT scans have enabled the early detection of disease and insight into physiology and anatomical function. In the same way, Accelerator Mass Spectrometry is remodeling the traditional pathways for drugs development into a more efficient and humane procedure. Efficiency comes from the ability to test new drug candidates very early in people with the assurance of safety and accuracy—humane, because AMS renders much animal testing unnecessary.

Vitalea Science is a leading developer and provider of bioanalytical measurements for drug development and biological research using Accelerator Mass Spectrometry, a highly specialized form of mass spectrometry that quantifies isotopes of carbon or calcium at unprecedented levels of sensitivity and precision.

As the most powerful analytical tool available to the industry, new avenues of research and modes of development being revealed.

Vitalea Science is at the forefront of a shift in the way drugs are developed and has assembled an experienced group of AMS investigators upon which to build its businesses. Vitalea Science was founded in 2003 and is headquartered in Davis, California.